CRISPR Therapeutics Announces Proposed Offering of Common Shares

ZUG, Switzerland and CAMBRIDGE, Mass. , June 29, 2020 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq:CRSP), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, today announced that it is commencing an underwritten public offering of